Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused Coronavirus
disease 2019 (COVID-19) in early December, 2019. The disease begins as a respiratory …

It is of interest to assess the inflammatory marker profile in SARS-CoV-2 patients and to
correlate the levels of systemic inflammatory biomarkers such as neutrophil-to-lymphocyte …

Background. Tissue damage caused by COVID‐19 could be detected by several clinical
indicators including hematological, immunological, biochemical, and inflammatory markers …

Background and objectives: For COVID-19 patients who need effective management, it is
necessary to identify the laboratory biomarkers of progression approaching morbidity and …

Materials and Methods: All confirmed cases of COVID-19 admitted in our tertiary care centre
from 1 st March 2021 to 31 st March 2021 were enrolled in the study. They were categorized …

Background: To analyze clinical features and laboratory indicators and identify the markers
of exacerbation in COVID-19. Methods: We reviewed clinical histories of 177 patients with …

Introduction: Accumulating evidence indicates that inflammatory responses play a major role
in the development and/or severity of coronavirus disease 2019 (COVID-19). Therefore, a …

The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) spread rapidly all over
the world in late 2019 and caused critical illness and death in some infected patients. This …

BACKGROUND Millions of people have died of coronavirus disease 2019 (COVID-19) due
to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and …

Background: Corona virus disease 2019 (Covid-19) has high infectivity and mortality rate.
Covid-19 patients can suddenly deteriorate and develop life threatening complications …